Since 1985, through our Translational Research Advancing Therapies for ALS (TREAT ALS™) program, The ALS Association has funded more than $99 million in research and clinical management projects. This unrelenting focus has resulted in some of the greatest ALS research discoveries to date.
From the earliest stages, The ALS Association has recognized novel approaches that have led to significant ALS research findings, including:
- The use of induced pluripotent stem cells generated from individuals skin cells for drug development;
- The movement of antisense therapy in genetic forms of ALS into clinical trials; and
- The identification of the C9orf72 gene, the single most important discovery in the field of ALS for two decades.
Leading the fight to treat and cure ALS through global research and nationwide advocacy while also empowering people with Lou Gehrig’s Disease and their families to live fuller lives by providing them with compassionate care and support
What We've Achieved
We’re presently funding close to 100 active research projects, selected through a peer review process involving top ALS scientists
- The groundbreaking discovery of a genetic abnormality that is, to date, the most common cause known of ALS and FTD.
- The recent exciting finding involved in familial ALS shows how two proteins work together to buttress the survival of motor neurons.